News | January 28, 2024
Novartis India posts Q3 FY24 PAT at Rs. 26.57 Cr
Novartis India has reported total income of Rs. 106.50 crores during the period ended December 31, 2023
Novartis India has reported total income of Rs. 106.50 crores during the period ended December 31, 2023
The company intends to respond to the two minor observations within the stipulated time
Astec LifeSciences has reported total income of Rs. 51.70 crores during the period ended December 31, 2023
Gabapentin is indicated for the management of Postherpetic Neuraligia
The registered capital of the newly founded company is € 50 million
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
The new campus has been designed as an employee-centred experience and ecosystem zone
Dr. Mandaviya also laid the foundation stone for an All India Institute of Speech and Hearing (AIISH) Satellite Centre in Kanpur
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
Laurus Labs has reported total income of Rs. 1197.35 crores during the period ended December 31, 2023
Subscribe To Our Newsletter & Stay Updated
